Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.QRxPharma Starts Pivotal Phase 3 Study Of MoxDuoIR
QRxPharma has initiated registration in the pivotal (Study 008) Phase 3 study of MoxDuoIR for moderate to severe acute pain. The company expects to complete dosing by close
QRxPharma has initiated registration in the pivotal (Study 008) Phase 3 study of MoxDuoIR for moderate to severe acute pain. The company expects to complete dosing by close
Spectrum Pharmaceuticals (Spectrum) has reported that one of the two Phase 3 pivotal clinical trials of Apaziquone has achieved its enrollment target, having enrolled approximately 800 patients with
Cromoz will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation
Theravance has received a complete response letter from the FDA related to the telavancin New Drug Application (NDA) for the treatment of nosocomial pneumonia (NP). Telavancin is a
Lundbeck has initiated a multi-centre, placebo-controlled, fixeddose study of Lu AE58054 as add-on to donepezil in patients with moderate alzheimer’s disease. The clinical Phase II study is planned
The European Commission has granted marketing authorisation for Sanofi’s Multaq (dronedarone – 400mg tablets) in all 27 European member states. This approval follows the European Commission positive opinion
Bayer Schering Pharma (Bayer Schering) has reported the enrollment of first patient in an international clinical Phase III trial to evaluate the efficacy and safety of Florbetaben (BAY
GlaxoSmithKline (GSK) has filed its vaccine for the prevention of rotavirus gastroenteritis (approved as Rotarix in a number of countries outside of Japan). The company claims that the
Kiadis Pharma (Kiadis) has reported the first patient enrollment in its multinational registration clinical trial with Atir. The study is designed to show reduction in Transplant Related Mortality
Lupin has reported that the FDA has started the inspection of its plant in Indore. After the company receives the approval from FDA, it is expected to initiate